So..they can make money by selling Nicosan as a neutracuetical in EU and USA,and as a treatment for SCD in Nigeria, which will bring in money.Then they can develop the 5HMF as an expensive pharmacuetical? If they can get through this rough patch it sounds like a good plan to me?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.